By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antiadrenergic agents, peripherally acting > Prazosin > Prazosin Dosage
Antiadrenergic agents, peripherally acting
https://themeditary.com/dosage-information/prazosin-dosage-6353.html

Prazosin Dosage

Drug Detail:Prazosin (Prazosin [ pra-zoe-sin ])

Drug Class: Antiadrenergic agents, peripherally acting

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hypertension

Initial dose: 1 mg orally 2 or 3 times a day
Maintenance dose: 1 to 20 mg orally per day in divided doses

Comments:

  • Titrate slowly as determined by blood pressure response.
  • Therapeutic dosages usually range from 6 to 15 mg per day in divided doses.
  • Total daily doses greater than 20 mg usually do not increase efficacy, but some patients may benefit from daily doses up to 40 mg per day in divided doses.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Adding a diuretic or another antihypertensive agent:

  • Reduce the dose of this drug to 1 or 2 mg three times a day and then retitrate.

Coadministration with phosphodiesterase-5 (PDE-5) inhibitors:
  • Initiate the PDE-5 inhibitor at the lowest dose.

Precautions

Safety and efficacy have not been established in children.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Storage requirements: Protect from light.

Monitoring:

  • Cardiovascular: Blood pressure (following the initial dose and dose adjustments)

Patient advice:
  • Advise patients how to avoid symptoms associated with lowering of blood pressure (e.g., dizziness, lightheadedness) and what to do if they occur. Also, encourage patients to avoid situations where injury could result if these symptoms occur.
  • Inform male patients about the seriousness of priapism and instruct them to seek immediate medical attention if it occurs.
  • Advise patients to report current or previous use of this drug to their ophthalmologist.
Share this Article
Latest News
Medical News

Early-stage Alzheimer's: New pill slows down neurodegeneration

Oct 26, 2025
Menopause: Study finds structural brain changes during transition
Shingles vaccine may reduce dementia, heart disease risk by 50%
Knee osteoarthritis: Are some exercises better than others?
Heart disease: 4,000 steps once or twice a week may help reduce risk
Vitamin D supplements: D3 may be more beneficial than D2
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by